Humira vs Rinvoq
Adalimumab vs Upadacitinib · Comparison Guide
Quick Comparison
| Feature | Humira | Rinvoq |
|---|---|---|
| Generic Name | Adalimumab | Upadacitinib |
| Manufacturer | AbbVie | AbbVie |
| Drug Class | TNF-alpha Inhibitor | JAK1 Inhibitor |
| Shared Conditions | Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, UC, Crohn's | |
Key Differences: Humira vs Rinvoq
Rinvoq is an oral tablet taken once daily; Humira is a subcutaneous injection every 2 weeks. Clinical trials (SELECT) showed Rinvoq numerically outperformed Humira on some RA endpoints. Rinvoq carries a black box warning for serious infections, malignancies, MACE, and thrombosis. Both are manufactured by AbbVie and have robust copay programs.
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
💊 Rinvoq (Upadacitinib)
- Class: JAK1 Inhibitor
- Manufacturer: AbbVie
- Full Rinvoq information →
Rinvoq is an oral tablet taken once daily; Humira is a subcutaneous injection every 2 weeks. Clinical trials (SELECT) showed Rinvoq numerically outperformed Humira on some RA endpoints. Rinvoq carries a black box warning for serious infections, malignancies, MACE, and thrombosis. Both are manufactured by AbbVie and have robust copay programs.
Neither Humira nor Rinvoq is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Humira and Rinvoq are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Humira and Rinvoq both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Humira and Rinvoq
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Humira and Rinvoq should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.